Clinical Trials Logo

Filter by:
NCT ID: NCT05558540 Not yet recruiting - Endometriosis Clinical Trials

Spinal Cord Stimulation for Intractable Chronic Lower Abdominal Neuropathic Pain Caused by Endometriosis

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Endometriosis is a chronic, inflammatory disease where endometrium-like tissue is present outside the uterus. Nerve cells in the proximity of this tissue express cytokine receptors causing a signaling cascade. This results in active cross-talk between endometriosis and nerves, causing pelvic pain. Other symptoms associated with endometriosis are cyclical such as dysmenorrhea and dysuria, and non-cyclical such as dyspareunia. Despite adequate disease management, women can still experience endometriosis-related pain. A recent development proven to be efficient in treatment of neuropathic pain, is Spinal Cord Stimulation (SCS). It is also thought to be effective in the treatment of visceral pain. Several studies found Spinal Cord Stimulation (SCS) to be effective in the reduction of endometriosis-related pelvic pain. However, scientific evidence on the efficacy of SCS in visceral pain is limited.

NCT ID: NCT05556512 Active, not recruiting - Obesity Clinical Trials

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

SURMOUNT-MMO
Start date: October 11, 2022
Phase: Phase 3
Study type: Interventional

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.

NCT ID: NCT05556096 Recruiting - Clinical trials for Generalized Myasthenia Gravis

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Start date: November 21, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of ALXN1720 for the treatment of generalized MG (gMG) in adults with autoantibodies against acetylcholine receptor (AChR).

NCT ID: NCT05555732 Recruiting - Clinical trials for Metastatic Non Small Cell Lung Cancer

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Start date: January 11, 2023
Phase: Phase 3
Study type: Interventional

This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab in combination with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer (NSCLC).

NCT ID: NCT05555498 Not yet recruiting - IVF Clinical Trials

Virtual Reality for Anxiety and Pain Management During Oocyte Retrieval in IVF/ICSI Treatment

VitRo
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Despite current anxiety and pain management during oocyte retrieval in IVF/ICSI treatment by conscious sedation, oocyte retrieval often remains painful and stressful for patients. An average pain score of 6.0 (expressed using VAS) and stress score of 41.63 (using STAI-S) were reported by previous researches. Previous research showed there might be a negative correlation between anxiety experienced in IVF/ICSI treatment, and ongoing pregnancy rate. Other researches nuance this. In addition, conscious sedation can give a variety of side effects such as apnea and respiratory depression. The appliance of Virtual Reality is increasingly researched, in a variety of procedures. Previous researches showed that Virtual Reality was effective in the reduction of anxiety and pain experienced, also in the field of Gynaecology and Obstetrics. We hypothesized that Virtual Reality can aid in the reduction of anxiety and pain experienced during oocyte retrieval in IVF/ICSI treatment. We also aim to find a definitive answer on the question whether anxiety during IVF/ICSI treatment can negatively influence ongoing pregnancy rates.

NCT ID: NCT05555472 Recruiting - Clinical trials for Juvenile Delinquency

The Youth Initiated Mentoring Approach for Juvenile Delinquents

Start date: September 13, 2022
Phase: N/A
Study type: Interventional

Natural or informal mentorship could potentially be considered effective in preventing or reducing delinquent behaviour. In the Youth Initiated Mentoring (YIM) approach, youths are supported by professionals in identifying and nominating a natural mentor within their own social network. The approach focuses on strengthening these naturally existing relationships with non-parental adults. Until now, little (quasi-)experimental research is conducted on the YIM approach. In the Netherlands, juvenile offenders between 12-18 years are referred to Halt, where they are required to follow a tailored intervention with the aim of preventing reoffending and increasing youths' future opportunities. Since 2019, the YIM approach is implemented as part of the Halt-intervention. The researchers will examine whether the YIM approach is an effective addition to the Halt-intervention. More specifically, whether it contributes to (1) strengthening youths' resilience, (2) decreasing or halting the need for formal support, and (3) decreasing or halting the development of juvenile delinquency. This quasi-experimental trial aims to include 300 youths referred to Halt. Youths will be non-randomly allocated to either a YIM trained Halt professional (N = 31), or a Halt professional not trained in the YIM approach (N = 31). These professionals will implement the Halt-plus-YIM-condition (N =150) or the care-as-usual Halt-condition (N = 150), respectively. Random allocation of youth cases to Halt professionals was not possible because Halt's distribution office considers individuals' workload. Despite non-random allocation, conditions will be comparable in terms of (1) the professionals who deliver the intervention (i.e., same educational level and from the same region), and (2) case type and severity (i.e., allocation is independent of type of offense and its severity as well as the evaluation of number of risk factors present in youth). Researchers will perform a multi-informant measurement strategy. Youths are our primary informants, but parents of youths are also approached to participate. Youth and parent questionnaires related to several youth and family outcomes will be administered at baseline, 100 days after baseline (post-test), and nine months after baseline (follow-up). Researchers will also collect information registered by Halt professionals in Halt's registration system. Read detailed description for more information on outcomes.

NCT ID: NCT05555199 Recruiting - Clinical trials for Early-stage Lung Cancer

Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

INITIATE
Start date: October 3, 2022
Phase: N/A
Study type: Interventional

The patient wil receive intra- or peritumoral injections of 99mTc-nanocolloid if malignancy is found during a navigation bronchoscopy. A SPECT/CT-scan will be made to image injections sites and sentinel lymph nodes (SLN). If surgery takes place to treat the lung cancer, ICG will be injected and fluorescent lymph nodes will be extensively assessed by a pathologist.

NCT ID: NCT05555017 Recruiting - Prostate Cancer Clinical Trials

Tracer-Guided Surgery for Recurrent Prostate Cancer

Trace-II
Start date: February 15, 2023
Phase: Phase 2
Study type: Interventional

ADT with or without robot-assisted PSMA-radioguided surgery for patients with recurrent prostate cancer.

NCT ID: NCT05554120 Enrolling by invitation - Smoking Cessation Clinical Trials

The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation

Start date: October 26, 2022
Phase:
Study type: Observational

Few countries have legislation to reduce the number and types of tobacco retail outlets. The Netherlands plans to ban tobacco sales in supermarkets in 2024. The overall aim of this proposed research is to evaluate the implementation of new legislation to reduce the number and types of tobacco outlets in the Netherlands, up until and including the ban on sales of tobacco in supermarkets. In a comprehensive policy evaluation, the investigators plan to examine (1) the impact of the policy on the number and types of tobacco outlets, (2) the impact on attitudes and behaviors of smoking adults and non-smoking youth, and (3) the influence of the tobacco industry on the policy process and the retail environment. In addition, the investigators plan to focus on differential effects in disadvantaged neighborhoods, where both smoking rates and tobacco outlet density are typically highest. The investigators bring together a unique combination of economic, psychological, and journalistic research methods. The investigators examine the impact of the new legislation on the amount and type of tobacco outlets and on the number of smokers by using routinely collected monitoring data. The investigators examine the impact of the legislation on smoking susceptibility of non-smoking youth and on impulse tobacco purchases by smoking adults with yearly quantitative surveys (two surveys before the policy implementation and two after) and with qualitative interviews and discussion sessions. The investigators examine whether these impacts differ for disadvantaged versus non-disadvantaged neighborhoods. The investigators examine what strategies the tobacco industry uses to influence the new legislation, policy processes, and the tobacco retail environment by performing a journalistic investigation, using for example documents obtained by Freedom of Information Act requests, (possibly) leaked documents from insider meetings, and interviews with insiders. Our research will provide a comprehensive evaluation of the effects of the implementation of the proposed legislative measures. Based on our results, the investigators will formulate recommendations for the Dutch Cancer Society, the Dutch government, and for other countries who consider reducing the number of tobacco outlets; highlight potential areas for further development and improvement within the legislative framework and provide recommendations on how to counter the lobby from the tobacco industry.

NCT ID: NCT05553808 Completed - Neoplasms Clinical Trials

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Start date: January 24, 2019
Phase: Phase 2
Study type: Interventional

This study is a sub-study of the master protocol 205801 (NCT03739710). This sub study has assessed the clinical activity of novel regimen (Feladilimab plus Docetaxel) with SOC (Docetaxel) in participants with NSCLC.